Clinical Trials
9 trialsNCT04482933 2026-02-10
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Pediatric Brain Tumor Consortium
Phase 2 Withdrawn
NCT01916187 2020-09-21
Imetelstat Given Intravenously Alone and With Standard 13-Cis-Retinoic Acid in Children With Neuroblastoma
Canadian Cancer Trials Group
Phase 1 Withdrawn
NCT02307604 2019-06-24
SPECTAbrain
European Organisation for Research and Treatment of Cancer - EORTC
Withdrawn
NCT01233479 2019-04-01
Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy
Pediatric Brain Tumor Consortium
Phase NA Withdrawn
NCT02011126 2018-08-07
Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors
Children's Oncology Group
Phase 2 Withdrawn
NCT00937417 2017-04-24
S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors
SWOG Cancer Research Network
Phase 1 Withdrawn
NCT00458744 2014-08-08
Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment
Children's Oncology Group
Phase 1 Withdrawn
NCT00897858 2013-04-19
Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors
Pediatric Brain Tumor Consortium
Withdrawn
NCT00053040 2010-09-24
Immunotoxin Therapy in Treating Children With Recurrent Malignant Gliomas
Pediatric Brain Tumor Consortium
Phase 1/2 Withdrawn